Abstract. Cholangiocarcinoma (CCA), a lethal malignancy afflicting many thousands of patients throughout the world, develops through a multi-step progression. We have established an oral thioacetamide-induced model of rat CCA recapitulating the histologic progression of human CCA, especially for mass-forming CCA (MF-CCA). Our previous DNA microarray study showed MUC4 is overexpressed in rat CCA. Herein, we investigated the prognostic value of MUC4 for predicting overall survival rate (OS) for MF-CCA patients undergoing hepatectomy. Overexpression of MUC4 in rat CCA is demonstrated by RT-PCR. From the archives of Chang Gung Memorial Hospital, 53 MF-CCA patients undergoing hepatectomy were selected for an immunohistochemical study of MUC4. Fifteen clinicopathological variables (including MUC4 staining status) were used for survival analysis. MUC 4 is overexpressed in rat CCA. Fifty-three MF-CCA patients, 26 men and 27 women, with a median age of 60 years (range: 29-89) were studied. During the median follow-up duration of 14.7 months, the OS rates at 1, 3, and 5 years were 58.8, 25.5, and 16.5%, respectively. Univariate analysis showed that an absence of physical findings, better nutritional status, small tumor size, negative lymph node metastasis, an absence of MUC4 staining, and curative hepatic resection were associated with favorable OS rate for MF-CCA patients after hepatectomy. However, multivariate Cox proportional hazard analysis showed that an absence of MUC4 staining, small tumor size, and curative hepatectomy independently predicted MF-CCA patients with favorable OS rate after hepatectomy. In conclusion, an absence of MUC4 staining, small tumor size, and curative hepatectomy could independently predict MF-CCA patients with favorable OS rate after hepatectomy.
Introduction
Peripheral cholangiocarcinoma (CCA) is a malignant tumor occurring in the liver or arising from the second or more distal branches of the intrahepatic bile ducts (1) . The incidence of CCA exhibits wide geographical variation, and generally accounts for between 5 and 30% of primary liver cancers (1) . CCA can be grossly classified into mass forming (MF), periductal infiltrating, and intraductal papillary types (2) . The MF type creates an apparent lesion in the liver, with frequent recurrence in the remnant liver after hepatic resection.
Clinically, CCA remains challenging and typically presents as an advanced disease. Curative resection with clear margins and without vascular or lymphatic invasion is infrequent and recurrence is common. Although liver transplantation has provided an alternative in the surgical management of CCA, high rates of CCA recurrence following transplantation limit liver transplantation for CCA patients (2) . Tumor biological behavior and early intrahepatic and extrahepatic spread limit the efficacy of surgery. Three-to five-year survival rates, even with resection, remain dismal (3) (4) (5) (6) (7) (8) . Moreover, radiation therapy or chemotherapy does not significantly improve long-term survival rates (6, 9) .
Significant progress has been made over the past decade in defining molecular alterations associated with CCA. Recent studies suggest that alterations in the tyrosine kinase receptors c-Erb-2/c-Neu and c-Met, along with possible aberrant autocrine expression of hepatocyte growth factor/ scatter factor, may play a crucial role in the pathogenesis of human CCA (10) (11) (12) . We had previously developed a reliable rat model of CCA obtained via oral administration of thioacetamide (13) . Since it recapitulates the dysplasiacarcinoma sequence of human CCA, this model is useful in shedding more light on the genetic basis of cholangiocellular neoplasia (13) .
Gene expression profiling using a DNA microarray is a powerful technique for understanding the molecular abnormalities underlying cancer. In our previous study (data not shown), we identified many differentially expressed genes of rat CCA, which could help us clarify the mechanism of carcinogenesis caused by TAA. Interestingly, among these genes we found MUC4 is over-expressed in rat CCA compared with the non-tumor liver tissue.
Mucins (MUC) are glycoproteins with oligosaccharides attached to serine or threonine residues of the mucin core protein backbone by O-glycosidic linkage. Human mucin core proteins, including MUC1 to MUC9, MUC11 to13, and MUC15 to17, were identified thereafter (14) (15) (16) (17) (18) (19) (20) (21) . MUC4 was first reported as tracheobronchial mucin (22) , and could be found expressed in various normal tissues (23) (24) (25) (26) . MUC4 was also proved to be an intramembrane ligand for receptor tyrosine kinase ErbB2, which is highly homologous with the epidermal growth factor receptor (27) (28) (29) .
Like MUC1, MUC4 is a poor prognostic factor in various human tumors (30) (31) (32) . In biliary epithelial cells, MUC4 was not expressed in the normal epithelium but in 67% of CCA (33) . However, the relationship between MUC4 expression and the patient's prognosis in MF-CCA is not well defined (34) . Therefore, in this study we analyzed the potential role of MUC4 as a candidate for one of the poor prognostic factors in MF-CCA patients undergoing hepatectomy.
Materials and methods
Quantitative real-time PCR. Quantitative real-time PCR (Q-RT-PCR) reactions were performed using SYBR GreenSuperMix (BioRad, Hercules, CA, USA) in 20 μl total volume and a BioRad iCycler iQ real-time detection system according to the manufacturer's instructions. The primers were designed using Beacon Designer software (Premier Biosoft International) and showed as follows: MUC4: forward 5'-ATACATCAACTACATCAGCC-3' and reverse 5'-CTCTGAGGAAGTGTTGTTAT-3' and housekeeping gene (ACTIN) forward 5'-GACAGGATGCAGAAGGA GAT-3' and reverse. 5'-CTGCTTGCTGATCCACATCT-3'. Q-RT-PCR cycle conditions were 3 min at 95˚C, 15 sec at 95˚C and 45 sec at 56˚C for 45 cycles. Performing primer matrix reactions and generating standard curves for MUC4 and ACTIN determined optimal PCR conditions. PCR reactions were performed in triplicate and the relative expression level of MUC4 in normal and tumor tissue was calculated by normalizing to ACTIN expression level using the comparative CT method. CT represents the cycle numbers at which the amplification reaches a threshold level chosen to lie in the exponential phase of all PCR reactions. Data were analyzed using the iCycle iQ system software (BioRad, Hercules, CA).
Immunohistochemical staining of MUC4 in rat CCA. A 4 μm section of thioacetamide induced rat CCA tissue was stained for MUC-4. The primary antibody MUC4 (mouse anti-MUC4 monoclonal antibody, ZYMED 35-4900) was diluted to 1:1500 and was added to the slides to be incubated overnight at 4˚C. The slides were then washed 3 times for 5 min in TBST before visualization with the 'Dako LSAB2 System, Peroxidase' (Dako A/S, No. K0675). Control slides were incubated with a secondary antibody only. After washing 3 times for 5 min each in TBST, the slides were mounted and blindly analyzed under microscope by authors.
Clinicopathological features of human CCA. CCA was defined as carcinoma arising from second order or more distal branches of the intrahepatic ducts. CCAs have been classified into three types based on the macroscopic appearance of the tumors, including mass-forming (MF), periductal infiltrating, and intraductal papillary type CCA. Curative resection was defined as negative resection margin observed during histopathological examination. Two patients were excluded from survival analysis due to surgical mortality. Surgical mortality is defined as death occurring within one month after surgery. Laboratory tests were conducted on the day before surgery. Serum carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) were measured by radioimmunoassay. The tumors were preoperatively evaluated by abdominal ultrasonography, endoscopic retrograde cholangiopancreatography, percutaneous transhepatic cholangiography, computed tomography, magnetic resonance image with cholangiopancreatography, and hepatic arteriography, as appropriate. Tumor stage was defined according to the pathological tumor node metastasis (pTNM system) classification proposed by the AJCC 6th edition. Adjuvant chemotherapy was systemically performed with a 5-flurouracil-based regimen due to either a positive section margin or local recurrence. C. Table I . Univariate analysis of factors influencing the overall survival of the 51 MF-CCA patients. 
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AST, aspartate aminotransferase; ALT, alanine amionotransferase; ALP, alkaline phosphatase; CEA, carcinoembryonic antigen; CA 19-9, carbohydrate antigen; IU, international unit.
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statistical analysis. P≤0.05 was considered statistically significant. Fig. 1A showed a significantly higher expression of MUC4 in six rat CCAs compared with six liver tissues of non-tumor parts demonstrated by quantitative real-time PCR. The fold of expression of MUC4 regarding tumor to a normal liver ranges from 1.74 to 18.81 folds.
Results

Quantitative real-time PCR.
MUC4 staining status in rat and human CCA. MUC4 is diffusely expressed in cytoplasmic and membranous distribution in human and rat CCA but is absent in normal hepatocyte (Fig. 1B) . 
Survival and prognostic analysis for human MF-CCA patients undergoing hepatectomy.
Fifty-three MF-CCA patients, including 26 men and 27 women with a median age of 60 years (range: 29-89 years), undergoing hepatectomy received regular follow-up until death. Two patients who died within one month after surgery were excluded from the survival analysis (surgical mortality rate: 3.8%). In total, 51 MF-CCA patients undergoing hepatectomy were enrolled in the survival analysis study. The follow-up duration ranged from 1.1 to 70.1 months (median, 14.7 months). Overall survival (OS) rates at 1, 3, and 5 years were 58.8%, 25.5%, and 16.5%, respectively (Fig. 3A) .
Univariate log-rank analysis identified adverse influences on OS rate of 51-MF CCA patients undergoing hepatectomy as follows: presence of symptoms, preoperative lower ONCOLOGY REPORTS 21: 49-56, 2009 53 Table II . Univariate analysis of factors influencing the overall survival of the 51 MF-CCA patients.
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albumin level, tumor size >5 cm, positive lymph node metastasis, MUC4 staining, and positive surgical margin status (Tables I and II) . Meanwhile, multivariate Cox's proportional hazard analysis demonstrated that tumor size >5 cm, presence of MUC4 staining, and non-curative hepatectomy were the three independent prognostic factors that adversely affected OS rates (Table III, Fig. 3B-D) .
Discussion
Although the molecular alterations involved in human CCA tumorigenesis have not been investigated thoroughly, our TAA induced rat CCA model may serve as a powerful preclinical platform. TTA and furan models of rat cholangiocarcinogenesis described that the receptors of tyrosine kinase c-Met and c-erb-B2 were overexpressed in the neoplastic glands of invasive CCAs, while absent or minimal in normal cholangiolar epithelium (13, 35) . Notably, striking up-regulation of the two oncogenes was noted in the epithelial cells of dysplastic glands as early as in the 9th week of TAA administration, and persisted into the invasive phase CCA (13, 35) . Recently, we demonstrated that MUC4 was overexpressed in TTA induced rat CCA by DNA microarray genomic study (data not shown). This study also showed an over-expression of MUC4 in rat CCA by quantitative RT-PCR and validated its prognostic value in human MF-CCA after hepatectomy.
This study used univariate and multivariate analysis to calculate overall survival (OS) rates of 53 MF-CCA patients after hepatic resection in terms of 15 clinicopathologic factors, including MUC-4 staining status. In univariate analysis, absence of physical findings, better nutritional status, small tumor size, negative lymph node metastasis, absence of MUC4 staining, and curative hepatic resection were associated with favorable OS rate for MF-CCA patients after hepatectomy. Applying the multivariate Cox's proportional hazard model to data from this investigation revealed that favorable overall survival depends on an absence of MUC4 staining, small tumor size, and curative hepatectomy.
MUC4 is normally expressed in normal tissues of the respiratory tract, stomach, small intestine, colon, and endocervix (23) (24) (25) (26) . Previously, MUC4 has been demonstrated as a novel intramembrane ligand for receptor tyrosine kinase Erb2 (28, 29) . Ascites sialoglycoprotein-2, the transmembrane subunit of MUC4, showed specific binding to Erb2, and MUC4 binding to Erb2 induced tyrosine phosphorylation of the receptor. MUC4 is the only ligand that has been characterized for ErbB2 (27, 29) . Clinically, MUC4 has been regarded as a candidate for a tumor marker of pancreatic adenocarcinoma and extrahepatic CCA. However, the relationship between MUC4 expression and the patient's prognosis in MF-CCA is limited (34) . Similar to Shibahara's report (34), we found that MUC4 expression was significantly related to poor survival of the patients with MF-CCA in univariate survival analysis, and that the MUC4 expression is an independent poor prognostic factor in patients with MF-CCA after hepatectomy.
Patients who had MF-CCA diagnosed asymptomatically and incidentally had a favorable survival, demonstrated by univariate survival analysis. However, this study revealed the fact that CCA remains clinically challenging because it is difficult to diagnose in its early stages, and patients typically do not present because of vague symptoms until the disease is quite advanced. This fact is demonstrated in more than half of the MF-CCA patients presented with tumor size >5 cm, so we should seek a certain novel tumor marker for the early detection of CCA in high-risk patient groups.
Diagnostic adjuncts for CCA, such as a serum marker, are useful for the clinical management of this disease. Several investigators have reported that CA 19-9 and CEA determinations are useful for diagnosing CCA in primary sclerosing cholangitis (36) . These investigators also demonstrated that serum CA 19-9 values are related to tumor burden and suggested that values were elevated in patients with CCA related to unresectable disease (36) . A previously conducted Japanese study also demonstrated that an elevated serum tumor marker, which includes CEA and CA19-9, was a predictor of a dismal prognosis (37) . Although the reason is unclear, this study did not demonstrate its role as predictors of prognosis for MF-CCA patients after hepatectomy.
A previously published Japanese report proposed a new staging system based mainly on the MF-type CCA to challenge the TNM staging system (38); however, this study reveals that a TNM staging system remains the most reliable prognostic factor for predicting the outcome of MF-CCA patients undergoing hepatectomy. Similar to the Japanese reports, lymph node metastasis is a reliable prognostic factor to in predicting a considerably worse prognosis, demonstrated by univariate survival analysis (39, 40) . MF-CCA patients with tumors >5 cm undergoing hepatectomy displayed a considerably worse prognosis as determined by Cox's multivariate proportional hazard analysis.
Hepatic resection is the preferred treatment for CCA (1) . This study demonstrated that MF-CCA patients undergoing 
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NS, not significant.
curative hepatic resection exhibited significantly better OS rates than those who did not. Similar to IP-CCA patients, an absence of curative hepatic resection in MF-CCA patients increased the chances of reducing long-term OS rate by 2.85 times according to Cox's multivariate proportional hazard analysis (41) (42) (43) (44) . This fact emphasizes that curative hepatic resection warrants a long-term OS rate.
In conclusion, a favorable long-term OS rate of MF-CCA patients undergoing hepatectomy depends on negative MUC4 staining, smaller tumor size, and curative hepatectomy.
